These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2172264)

  • 1. Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography.
    Chong P; Jackson G; Cwyk W; Klein M
    J Chromatogr; 1990 Jul; 512():227-36. PubMed ID: 2172264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
    Semina IE; Iankina ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.
    Ibsen PH; Petersen JW; Heron I
    Vaccine; 1993; 11(3):318-22. PubMed ID: 8447160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
    Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydromechanical forces on the production of filamentous haemagglutinin and pertussis toxin of Bordetella pertussis.
    Rodríguez ME; Samo AL; Hozbor DF; Yantorno OM
    J Ind Microbiol; 1993 Feb; 12(2):103-8. PubMed ID: 7764157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of pertussis toxin subunit proteins by reverse-phase high-performance liquid chromatography and reconstitution of the holotoxin molecule.
    Yamakawa Y; Sato H; Sato Y
    Anal Biochem; 1990 Feb; 185(1):176-81. PubMed ID: 2344043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography.
    Ozcengiz E; Kilinç K; Büyüktanir O; Günalp A
    Vaccine; 2004 Mar; 22(11-12):1570-5. PubMed ID: 15063583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The property of filamentous hemagglutinin of Bordetella pertussis].
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):331-8. PubMed ID: 1845342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutinin.
    Krell T; Greco F; Nicolaï MC; Dubayle J; Renauld-Mongénie G; Poisson N; Bernard I
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):241-51. PubMed ID: 12911336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterisation of the pertussis vaccine.
    Ceccarini C; Contorni M; Costantino P; D'Ascenzi S; Gallo E; Maffei M; Mannucci D; Marsili I; Magagnoli C; Peppoloni S; Rappuoli R; Ravenscroft N; Ricci S
    Dev Biol (Basel); 2000; 103():175-88. PubMed ID: 11214235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis.
    Suzuki Y; Imaizumi A; Ginnaga A; Sato H; Sato Y
    Dev Biol Stand; 1985; 61():89-92. PubMed ID: 2872134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid purification of Bordetella pertussis toxin by alternating affinity and hydrophobic chromatography.
    Svoboda M; Hannecart-Pokorni E; Borremans M; Christophe J
    Anal Biochem; 1986 Dec; 159(2):402-11. PubMed ID: 3826625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
    Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
    Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive chemiluminescence assay for pertussis toxin and for evaluation of cell-free pertussis toxoids.
    Craig FF; Christodoulides M; Parton R; Stewart-Tull DE; Freer JH; Lackie JM
    FEMS Microbiol Immunol; 1988 Jul; 1(2):75-9. PubMed ID: 3273462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemagglutination activities of purified pertussis toxin and filamentous hemagglutinin against erythrocytes from various animals.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Microbiol Immunol; 1990; 34(9):795-9. PubMed ID: 2283955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.